ArticleJournal of the American Heart Association2019

Sphingomyelin Synthase 2 Inhibition Ameliorates Cerebral Ischemic Reperfusion Injury Through Reducing the Recruitment of Toll-Like Receptor 4 to Lipid Rafts.

Jing Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.